| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Pfizer, Inc. | 75,990 | 93,450 |
| Rockwood Holdings, Inc. | 90,400 | 157,600 |
| Occidental Petroleum Corp | 60,488 | 56,931 |
| California Resources Corp | 2,184 | 1,543 |
| Ziopharm Oncology Inc | 24,905 | 50,700 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Zazove | 464,372 | 635,767 | |
| Xanthus | 215,441 | 232,811 |
| Description | Amount |
|---|---|
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Xathanus pass through losses | 13,231 | 13,231 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Xanthus K-1 pass thru income | 11,224 | 11,224 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Federal Taxes Payable | 248 | |
| Federal Taxes Payable | 248 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Federal Taxes Payable | 248 | |
| Federal Taxes Payable | 248 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Federal Taxes | 18 | |||
| Xanthus K-1 pass thru invst int | 1,913 | 1,913 |